Seetharamu, N <br/><br/>
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.  [electronic resource] 

 -  Anticancer research  Feb 2010 
 - 541-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma, Papillary--drug therapy<br/>Adult<br/>Cisplatin--therapeutic use<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Prognosis